M2e-based universal influenza A vaccine.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Vaccine

• Publication date

  2009-10-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2009.07.007PMID 19840661
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection

  2011cited by this paper
• Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype.

  2010cited by this paper
• Molecular characterization of two hantavirus strains from different rattus species in Singapore

  2010cited by this paper
• Influenza virus activates inflammasomes through intracellular M2 channel

  2010cited by this paper
• Proton and cation transport activity of the M2 proton channel from influenza A virus

  2010cited by this paper
• Genetic control of immune responses to influenza A matrix 2 protein (M2).

  2010cited by this paper
• An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses

  2010cited by this paper
• Animal models for the preclinical evaluation of candidate influenza vaccines

  2010cited by this paper
• Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses

  2010cited by this paper
• Influenza Virus M2 Ion Channel Protein Is Necessary for Filamentous Virion Formation

  2010cited by this paper
• Influenza virus M2 protein mediates ESCRT-independent membrane scission.

  2010cited by this paper
• Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin.

  2010cited by this paper
• Immunopathology and Infectious Disease Human and Avian Influenza Viruses Target Different Cells in the Lower Respiratory Tract of Humans and Other Mammals

  2010cited by this paper
• Insight into the Mechanism of the Influenza A Proton Channel from a Structure in a Lipid Bilayer

  2010cited by this paper
• Estimates of deaths associated with seasonal influenza --- United States, 1976-2007.

  2010cited by this paper
• Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice.

  2010cited by this paper
• A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody

  2010cited by this paper
• Immunopotentiation of Trivalent Influenza Vaccine When Given with VAX102, a Recombinant Influenza M2e Vaccine Fused to the TLR5 Ligand Flagellin

  2010cited by this paper
• Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus

  2010cited by this paper
• An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus

  2010cited by this paper
• Molecular dynamics calculations suggest a conduction mechanism for the M2 proton channel from influenza A virus

  2009cited by this paper
• Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys.

  2009influential reference
• Yearly influenza vaccinations: a double-edged sword?

  2009cited by this paper
• Chicken IgY Binds Its Receptor at the CH3/CH4 Interface Similarly as the Human IgA:FcαRI Interaction1

  2009cited by this paper
• Mechanism of drug inhibition and drug resistance of influenza A M2 channel

  2009cited by this paper
• DNA vaccines in veterinary use

  2009cited by this paper
• Vaccination of chickens with recombinant Salmonella expressing M2e and CD154 epitopes increases protection and decreases viral shedding after low pathogenic avian influenza challenge.

  2009influential reference
• Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes.

  2009cited by this paper
• Host Genetic Background Strongly Influences the Response to Influenza A Virus Infections

  2009cited by this paper
• Vaccination against Human Influenza A/H3N2 Virus Prevents the Induction of Heterosubtypic Immunity against Lethal Infection with Avian Influenza A/H5N1 Virus

  2009cited by this paper
• Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus.

  2009cited by this paper
• Proteolytic Activation of the 1918 Influenza Virus Hemagglutinin

  2009cited by this paper
• Autophagy, immunity, and microbial adaptations.

  2009cited by this paper
• CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine.

  2008cited by this paper
• Structure and mechanism of the M2 proton channel of influenza A virus

  2008cited by this paper
• Efficient induction of mucosal and systemic immune responses by virus‐like particles administered intranasally: implications for vaccine design

  2008cited by this paper
• Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.

  2008cited by this paper
• The pig as a mixing vessel for influenza viruses: Human and veterinary implications

  2008cited by this paper
• An Influenza A Vaccine Based on Tetrameric Ectodomain of Matrix Protein 2*

  2008cited by this paper
• Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein.

  2008cited by this paper
• Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform.

  2008cited by this paper
• Study of influenza C virus infection in France

  2008cited by this paper
• Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus.

  2008cited by this paper
• Structural basis for the function and inhibition of an influenza virus proton channel

  2008cited by this paper
• Matrix Protein 2 Vaccination and Protection against Influenza Viruses, Including Subtype H5N1

  2007cited by this paper
• Development of an M2e-Specific Enzyme-Linked Immunosorbent Assay for Differentiating Infected from Vaccinated Animals

  2007cited by this paper
• Characterization of immunity induced by M2e of influenza virus.

  2007cited by this paper
• Viroporins from RNA viruses induce caspase‐dependent apoptosis

  2007cited by this paper
• The chicken leukocyte receptor complex encodes a primordial, activating, high-affinity IgY Fc receptor

  2007cited by this paper
• Vaccines for preventing influenza in healthy adults.

  2007cited by this paper
• Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse

  2007cited by this paper
• Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

  2007cited by this paper
• Clinical features of influenza C virus infection in children.

  2006cited by this paper
• Improved design and intranasal delivery of an M2e-based human influenza A vaccine.

  2006cited by this paper
• Distinct Domains of the Influenza A Virus M2 Protein Cytoplasmic Tail Mediate Binding to the M1 Protein and Facilitate Infectious Virus Production

  2006cited by this paper
• The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection.

  2006cited by this paper
• Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines.

  2006cited by this paper
• Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2

  2006cited by this paper
• The Influenza A Virus M2 Cytoplasmic Tail Is Required for Infectious Virus Production and Efficient Genome Packaging

  2005cited by this paper
• Influenza Type A Virus Escape Mutants Emerge In Vivo in the Presence of Antibodies to the Ectodomain of Matrix Protein 2

  2005cited by this paper
• Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.

  2005cited by this paper
• High epitope density in a single protein molecule significantly enhances antigenicity as well as immunogenicity: a novel strategy for modern vaccine development and a preliminary investigation about B cell discrimination of monomeric proteins

  2005cited by this paper
• Universal influenza A vaccine: optimization of M2-based constructs.

  2005cited by this paper
• Influence of residue 44 on the activity of the M2 proton channel of influenza A virus.

  2005cited by this paper
• The Ferret: An Animal Model to Study Influenza Virus

  2004cited by this paper
• Human and avian influenza viruses target different cell types in cultures of human airway epithelium.

  2004cited by this paper
• Intranasal influenza vaccine in a working population.

  2004cited by this paper
• High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity.

  2004cited by this paper
• Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys.

  2004influential reference
• Influenza A Vaccine Based on the Extracellular Domain of M2: Weak Protection Mediated via Antibody-Dependent NK Cell Activity

  2004cited by this paper
• The Cholera Toxin-Derived CTA1-DD Vaccine Adjuvant Administered Intranasally Does Not Cause Inflammation or Accumulate in the Nervous Tissues1

  2004cited by this paper
• Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge.

  2004cited by this paper
• Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2.

  2003cited by this paper
• T-cell hybridomas from HLA-transgenic mice as tools for analysis of human antigen processing.

  2003cited by this paper
• N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication

  2003cited by this paper
• Increased Efficacy of the Immunoglobulin G2a Subclass in Antibody-Mediated Protection against Lactate Dehydrogenase-Elevating Virus-Induced Polioencephalomyelitis Revealed with Switch Mutants

  2002cited by this paper
• Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus.

  2002cited by this paper
• Updating the Accounts: Global Mortality of the 1918-1920 "Spanish" Influenza Pandemic

  2002cited by this paper
• Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene.

  2001cited by this paper
• Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection.

  2001cited by this paper
• Human memory CTL response specific for influenza A virus is broad and multispecific.

  2000cited by this paper
• Modified M2 proteins produce heterotypic immunity against influenza A virus.

  1999cited by this paper
• A universal influenza A vaccine based on the extracellular domain of the M2 protein

  1999influential reference
• Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species.

  1999cited by this paper
• Human Cytotoxic T-Lymphocyte Repertoire to Influenza A Viruses

  1998cited by this paper
• Molecular Basis for the Generation in Pigs of Influenza A Viruses with Pandemic Potential

  1998cited by this paper
• Cold-adapted live attenuated influenza vaccines developed in Russia: Can they contribute to meeting the needs for influenza control in other countries?

  1997cited by this paper
• The impact of influenza epidemics on mortality: introducing a severity index.

  1997cited by this paper
• One gene encodes the heavy chains for three different forms of IgY in the duck.

  1994cited by this paper
• Antibody response to the M2 protein of influenza A virus expressed in insect cells.

  1993cited by this paper
• The influence of antigen organization on B cell responsiveness.

  1993cited by this paper
• A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains

  1993cited by this paper
• Maturation of influenza A virus hemagglutinin--estimates of the pH encountered during transport and its regulation by the M2 protein.

  1992cited by this paper
• Unpacking the incoming influenza virus.

  1992cited by this paper
• Evidence that the amantadine-induced, M2-mediated conversion of influenza A virus hemagglutinin to the low pH conformation occurs in an acidic trans Golgi compartment.

  1992cited by this paper
• The geography and mortality of the 1918 influenza pandemic.

  1991cited by this paper
• Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins

  1991cited by this paper
• Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice

  1990cited by this paper
• Overview of the mucosal immune system.

  1989cited by this paper
• Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions

  1988cited by this paper

• Pentameric M2e influenza vaccine candidate generates strong immunity with limited survival benefit

  2026influential citation
• Brief Comparison of Novel Influenza Vaccine Design Strategies

  2025cites this paper
• Chimeric Virus-like Particles Formed by the Coat Proteins of Single-Stranded RNA Phages Beihai32 and PQ465, Simultaneously Displaying the M2e Peptide and the Stalk HA Peptide from Influenza a Virus, Elicit Humoral and T-Cell Immune Responses in Mice

  2025cites this paper
• Virus-like particles of Macrobrachium rosenbergii nodavirus displaying M2e of influenza A viruses protect White Leghorn chickens against heterologous H9N2 and H5N2 challenges.

  2025cites this paper
• Influenza A Vaccine Candidates Based on Virus-like Particles Formed by Coat Proteins of Single-Stranded RNA Phages Beihai32 and PQ465

  2024cites this paper
• Polymeric cGAMP microparticles affect the immunogenicity of a broadly active influenza mRNA lipid nanoparticle vaccine.

  2024cites this paper
• DEVELOPMENT OF HIGHLY PATHOGENIC AVIAN INFLUENZA VACCINE FOR PANDEMIC INFLUENZA PREPAREDNESS: A REVIEW

  2024cites this paper
• A Modular Bacteriophage T4 Nanoparticle Platform Enables Rapid Design of Dual COVID‐19‐Flu Mucosal Vaccines

  2024cites this paper
• Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing.

  2024cites this paper
• Construction with recombinant epitope-expressing baculovirus enhances protective effects of inactivated H9N2 vaccine against heterologous virus.

  2024cites this paper
• Delivery of gold nanoparticle-conjugated M2e influenza vaccine in mice using coated microneedles.

  2023cites this paper
• Thermal-triggered loading and GSH-responsive releasing property of HBc particles for drug delivery.

  2023cites this paper
• Induction of Homosubtypic and Heterosubtypic Immunity to Influenza Viruses Using a Conserved Internal and External Proteins

  2023cites this paper
• Immunogenicity of an adjuvanted broadly active influenza vaccine in immunocompromised and diverse populations

  2023cites this paper
• Trivalent inactivated influenza vaccine response and immunogenicity assessment after one week and three months in repeatedly vaccinated adults

  2023cites this paper
• Viral protein-based nanoparticles (Part 2): Pharmaceutical applications.

  2023cites this paper
• An experimental universal swine influenza a virus (IAV) vaccine candidate based on the M2 ectodomain (M2e) peptide does not provide protection against H1N1 IAV challenge in pigs.

  2023cites this paper
• Protective Efficacy of a Mucosal Influenza Vaccine Formulation Based on the Recombinant Nucleoprotein Co-Administered with a TLR2/6 Agonist BPPcysMPEG

  2023cites this paper
• High-Yield Production of Chimeric Hepatitis E Virus-Like Particles Bearing the M2e Influenza Epitope and Receptor Binding Domain of SARS-CoV-2 in Plants Using Viral Vectors

  2022cites this paper
• R848 Adjuvant Laden With Self-Assembled Nanoparticle-Based mRNA Vaccine Elicits Protective Immunity Against H5N1 in Mice

  2022cites this paper
• Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses

  2022cites this paper
• Inside and outside of virus-like particles HBc and HBc/4M2e: a comprehensive study of the structure

  2022cites this paper
• Progress towards the Development of a Universal Influenza Vaccine

  2022cites this paper
• Expression of Influenza M2e-NP Recombinant Fusion Protein in Escherichia coli BL21 (DE3) and Its Binding to Antibodies

  2022cites this paper
• Editorial: Pandemic influenza vaccine approaches: Current status and future directions

  2022cites this paper
• A Glu-Glu-Tyr Sequence in the Cytoplasmic Tail of the M2 Protein Renders Influenza A Virus Susceptible to Restriction of the Hemagglutinin-M2 Association in Primary Human Macrophages

  2022cites this paper
• Nano/microparticle Formulations for Universal Influenza Vaccines

  2022cites this paper
• An Antigenic Thrift-Based Approach to Influenza Vaccine Design

  2021cites this paper
• A M2 protein-based universal influenza vaccine containing Advax-SM adjuvant provides newborn protection via maternal or neonatal immunization.

  2021cites this paper
• Animal Models Utilized for the Development of Influenza Virus Vaccines

  2021cites this paper
• Nanoparticles based on artificial self-assembling peptide and displaying M2e peptide and stalk HA epitopes of influenza a virus induces potent humoral and T-cell responses and protects against the viral infection.

  2021cites this paper
• Elicitation of Highly Pathogenic Avian Influenza H5N1 M2e and HA2-Specific Humoral and Cell-Mediated Immune Response in Chicken Following Immunization With Recombinant M2e–HA2 Fusion Protein

  2021cites this paper
• The Next Generation of Influenza Vaccines: Towards a Universal Solution

  2021cites this paper
• Understanding Host Immunity and the Gut Microbiota Inspires the New Development of Vaccines and Adjuvants

  2021cites this paper
• M2e conjugated gold nanoparticle influenza vaccine displays thermal stability at elevated temperatures and confers protection to ferrets.

  2021cites this paper
• Development of a Novel Live Attenuated Influenza A Virus Vaccine Encoding the IgA-Inducing Protein

  2021cites this paper
• M2e-Based Influenza Vaccines with Nucleoprotein: A Review

  2021cites this paper
• Combination of conserved recombinant proteins (NP & 3M2e) formulated with Alum protected BALB/c mice against influenza A/PR8/H1N1 virus challenge

  2021cites this paper
• A Host-Restricted Self-Attenuated Influenza Virus Provides Broad Pan-Influenza A Protection in a Mouse Model

  2021cites this paper
• Bacteriophage T4 Vaccine Platform for Next-Generation Influenza Vaccine Development

  2021cites this paper
• Generation and Characterization of Universal Live-Attenuated Influenza Vaccine Candidates Containing Multiple M2e Epitopes

  2020cites this paper
• Virus-like Particle Vaccines: A Prospective Panacea Against an Avian Influenza Panzootic

  2020cites this paper
• Highly Immunogenic Nanoparticles Based on a Fusion Protein Comprising the M2e of Influenza A Virus and a Lipopeptide

  2020cites this paper
• Mosaic vaccination: How distributing different vaccines across a population could improve epidemic control

  2020cites this paper
• Flu Universal Vaccines: New Tricks on an Old Virus

  2020cites this paper
• A vaccine combination of lipid nanoparticles and a cholera toxin adjuvant derivative greatly improves lung protection against influenza virus infection

  2020cites this paper
• Emerging methods in therapeutics using multifunctional nanoparticles.

  2020cites this paper
• Identification of a novel TLR5 agonist derived from the P97 protein of Mycoplasma hyopneumoniae.

  2020cites this paper
• Oral immunization with an attenuated Salmonella Gallinarum encoding the H9N2 haemagglutinin and M2 ectodomain induces protective immune responses against H9N2 infection in chickens

  2020influential citation
• Designing a chimeric subunit vaccine for influenza virus, based on HA2, M2e and CTxB: a bioinformatics study

  2020cites this paper
• Tetramerizing tGCN4 domain facilitates production of Influenza A H1N1 M2e higher order soluble oligomers that show enhanced immunogenicity in vivo

  2020cites this paper
• An approach to the influenza chimeric subunit vaccine (3M2e-HA2-NP) provides efficient protection against lethal virus challenge

  2020cites this paper
• Three Options Against Sars-Cov-2: Pediatric Sera, Mithridatization, Dewetting Antibodies

  2020cites this paper
• Evaluation of Self-Adjuvanting M2e Vaccine Efficacy in Response to Influenza A Virus Challenge

  2020cites this paper
• Intranasally administered protein coated chitosan nanoparticles encapsulating influenza H9N2 HA2 and M2e mRNA molecules elicit protective immunity against avian influenza viruses in chickens

  2020cites this paper
• Next-generation influenza vaccines: opportunities and challenges

  2020cites this paper
• Dewetting Antibodies Against Viroporins Might Contribute to Decrease 2019-Ncov Infection Spread

  2020cites this paper
• Expression of influenza A virus-derived peptides on a rotavirus VP6-based delivery platform

  2020cites this paper
• Complexes Formed via Bioconjugation of Genetically Modified TMV Particles with Conserved Influenza Antigen: Synthesis and Characterization

  2020cites this paper
• Better influenza vaccines: an industry perspective

  2020cites this paper
• 4th Applied Synthetic Biology in Europe

  2020cites this paper
• Universal Vaccines against Influenza Viruses: Overview of the Past, Present, and Prospective

  2020cites this paper
• Synthesis and Assembly of Hepatitis B Virus-Like Particles in a Pichia pastoris Cell-Free System

  2020cites this paper
• A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice.

  2020cites this paper
• Plant-Produced Recombinant Influenza A Virus Candidate Vaccine Based on Flagellin Linked to Conservative Fragments of M2 Protein and Hemagglutintin

  2020cites this paper
• Why are vaccines against many human viral diseases still unavailable; an historic perspective?

  2019cites this paper
• Protective immunity against influenza virus challenge by norovirus P particle-M2e and HA2-AtCYN vaccines in chickens.

  2019cites this paper
• An Inactivated Influenza Virus Vaccine Approach to Targeting the Conserved Hemagglutinin Stalk and M2e Domains

  2019cites this paper
• AuNP-M2e + sCpG vaccination of juvenile mice generates lifelong protective immunity to influenza A virus infection

  2019cites this paper
• The Quest for a Truly Universal Influenza Vaccine

  2019cites this paper
• M2e-based universal influenza vaccines: a historical overview and new approaches to development

  2019cites this paper
• Cloning and expression of virus-like particles (VLPs) in microalgal expression systems

  2019cites this paper
• Characterization of Toll-like Receptor 7 / 8 Agonist Amino Acid for Antigen-Adjuvant Conjugation Co-delivery System

  2019cites this paper
• Vaccine Targets Expanding from Infectious Diseases to Non-infectious Diseases

  2019cites this paper
• Current and Novel Approaches in Influenza Management

  2019cites this paper
• Protective Antibodies Against Influenza Proteins

  2019cites this paper
• Plant Viruses in Plant Molecular Pharming: Toward the Use of Enveloped Viruses

  2019cites this paper
• An amphiphilic invertible polymer as a delivery vehicle for a M2e-HA2-HA1 peptide vaccine against an Influenza A virus in pigs.

  2019cites this paper
• Human antigen presenting cells stimulated with Salmonella delivered influenza antigens induce cytokine production and proliferation of human CD4+ T cells in vitro.

  2019cites this paper
• Identification of a Novel Universal Potential Epitope on the Cytoplasmic Tail of H7N9 Virus Hemagglutinin

  2019cites this paper
• Influenza A virus and related secondary bacterial infections

  2019cites this paper
• Towards Dewetting Monoclonal Antibodies For Therapeutical Purposes.

  2019cites this paper
• Intranasally administered polyethylenimine adjuvanted influenza M2 ectodomain induces partial protection against H9N2 influenza A virus infection in chickens.

  2019cites this paper
• Targeting M2e to DEC-205 induces an enhanced serum antibody-dependent heterosubtypic protection against influenza A virus infection.

  2019cites this paper
• Dynamic Perspectives on the Search for a Universal Influenza Vaccine.

  2019cites this paper
• Evaluation of Protective Immunity of Peptide Vaccines Composed of a 15-mer N-terminal Matrix Protein 2 and a Helper T-Cell Epitope Derived from Influenza A Virus

  2019cites this paper
• Respiratory virus-induced heterologous immunity

  2018cites this paper
• Salmonella Gallinarum delivering M2eCD40L in protein and DNA formats acts as a bivalent vaccine against fowl typhoid and H9N2 infection in chickens

  2018cites this paper
• The quest for a nanoparticle-based vaccine inducing broad protection to influenza viruses.

  2018cites this paper
• Influenza vaccine: Where are we and where do we go?

  2018cites this paper
• Influence of the Linking Order of Fragments of HA2 and M2e of the influenza A Virus to Flagellin on the Properties of Recombinant Proteins

  2018cites this paper
• Flagellin as a vaccine adjuvant

  2018cites this paper
• Oral immunization with a novel attenuated Salmonella Typhimurium encoding influenza HA, M2e and NA antigens protects chickens against H7N9 infection

  2018cites this paper
• Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice

  2018cites this paper
• Investigation of tunable acetalated dextran microparticle platform to optimize M2e‐based influenza vaccine efficacy

  2018cites this paper
• Monoclonal antibody against the universal M2 epitope of influenza A virus

  2018cites this paper
• Generation of a broadly reactive influenza H1 antigen using a consensus HA sequence.

  2018cites this paper
• Novel Platforms for the Development of a Universal Influenza Vaccine

  2018cites this paper
• A novel peptide-based vaccine candidate with protective efficacy against influenza A in a mouse model.

  2018cites this paper
• Expression in Plants of a Recombinant Protein Based on Flagellin Linked to Conservative Fragments of M2 Protein and Hemagglutintin of Influenza Virus

  2018cites this paper